You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

ORIGINAL RESEARCH article

Front. Med.

Sec. Pulmonary Medicine

Synergistic Interactions of Melatonin and Glucocorticoids in Alleviating Allergic Airway Inflammation

  • 1. The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, Huai'an, China

  • 2. First Affiliated Hospital of Soochow University, Suzhou, China

Article metrics

View details

192

Views

The final, formatted version of the article will be published soon.

Abstract

Abstract Background: This study investigates the synergistic effects of melatonin and glucocorticoids in the management of asthma and allergic airway inflammation. While glucocorticoids are the cornerstone of asthma treatment, melatonin's anti-inflammatory properties, potentially mediated through circadian rhythm regulation, may enhance their therapeutic efficacy. Methods: A case-control clinical study was conducted to assess asthma control scores, biochemical markers, exhaled nitric oxide (FeNO), and sleep quality. Additionally, an animal model was utilized to evaluate the effects of melatonin and dexamethasone combination therapy on airway inflammation and circadian rhythm gene expression. Results: The clinical study found significant correlations between asthma control scores, melatonin and PSQI sleep quality, suggesting that melatonin play crucial roles in asthma control. In parallel, animal experiments revealed that melatonin reduced allergic airway inflammation and stabilized circadian rhythm gene expression. Furthermore, the combination of melatonin with glucocorticoids exhibited a significantly enhanced effect in reducing allergic airway inflammation. Conclusion: Melatonin, when combined with corticosteroids, may represent a promising therapeutic strategy for allergic asthma, potentially improving asthma control through modulation of inflammation and circadian rhythm regulation. Further studies are needed to fully elucidate the mechanisms underlying this synergy and to evaluate the long-term therapeutic benefits.

Summary

Keywords

allergic diseases, Asthma, Circadian Rhythm, Glucocorticoids therapy, Melatonin

Received

04 November 2025

Accepted

30 January 2026

Copyright

© 2026 Baolan, zhang, Wang, Ma, Zhang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Wang Baolan

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Share article

Article metrics